Novel Variant of FDXR as a Molecular Etiology of Postlingual Post-synaptic Auditory Neuropathy Spectrum Disorder via Mitochondrial Dysfunction: Reiteration of the Correlation between Genotype and Cochlear Implantation Outcomes
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives. FDXR encodes mitochondrial ferredoxin reductase, which is associated with auditory neuropathy spectrum disorder (ANSD) and optic atrophy. To date, only two studies have described FDXR-related hearing loss. The auditory rehabilitation outcomes of this disease entity have not been investigated, and the pathophysiological mechanisms re- main incompletely understood. Here we report a hearing-impaired individual with co-segregation of the FDXR vari- ant and post-synaptic type ANSD, who underwent cochlear implantation (CI) with favorable outcomes. We suggest a possible pathophysiological mechanism of adult-onset ANSD involving mitochondrial dysfunction. Methods. A 35-year-old woman was ascertained to have ANSD. Exome sequencing identified the genetic cause of hearing loss, and a functional study measuring mitochondrial activity was performed to provide molecular evidence of patho- physiology. Expression of FDXR in the mouse cochlea was evaluated by immunohistochemistry. Intraoperatively, elec- trically evoked compound action potential (ECAP) responses were measured, and the mapping parameters were ad- justed accordingly. Audiological outcomes were monitored for over 1 year. Results. In lymphoblastoid cell lines (LCLs) carrying a novel FDXR variant, decreased ATP levels, reduced mitochondrial membrane potential, and increased reactive oxygen species levels were observed compared to control LCLs. These dysfunctions were restored by administering mitochondria isolated from umbilical cord mesenchymal stem cells, con- firming the pathogenic potential of this variant via mitochondrial dysfunction. Partial ECAP responses during CI and FDXR expression in the mouse cochlea indicate that FDXR-related ANSD is post-synaptic. As a result of increasing the pulse width during mapping, the patient’s CI outcomes showed significant improvement over 1-year post-CI. Conclusion. A novel FDXR variant associated with mitochondrial dysfunction and post-synaptic ANSD was first identified in a Korean individual. Additionally, 1-year post-CI outcomes were reported for the first time in the literature. Excel- lent audiologic results were obtained, and our results reiterate the correlation between genotype and CI outcomes in ANSD.
Abstract
Objectives. FDXR encodes mitochondrial ferredoxin reductase, which is associated with auditory neuropathy spectrum disorder (ANSD) and optic atrophy. To date, only two studies have described FDXR-related hearing loss. The auditory rehabilitation outcomes of this disease entity have not been investigated, and the pathophysiological mechanisms re- main incompletely understood. Here we report a hearing-impaired individual with co-segregation of the FDXR vari- ant and post-synaptic type ANSD, who underwent cochlear implantation (CI) with favorable outcomes. We suggest a possible pathophysiological mechanism of adult-onset ANSD involving mitochondrial dysfunction. Methods. A 35-year-old woman was ascertained to have ANSD. Exome sequencing identified the genetic cause of hearing loss, and a functional study measuring mitochondrial activity was performed to provide molecular evidence of patho- physiology. Expression of FDXR in the mouse cochlea was evaluated by immunohistochemistry. Intraoperatively, elec- trically evoked compound action potential (ECAP) responses were measured, and the mapping parameters were ad- justed accordingly. Audiological outcomes were monitored for over 1 year. Results. In lymphoblastoid cell lines (LCLs) carrying a novel FDXR variant, decreased ATP levels, reduced mitochondrial membrane potential, and increased reactive oxygen species levels were observed compared to control LCLs. These dysfunctions were restored by administering mitochondria isolated from umbilical cord mesenchymal stem cells, con- firming the pathogenic potential of this variant via mitochondrial dysfunction. Partial ECAP responses during CI and FDXR expression in the mouse cochlea indicate that FDXR-related ANSD is post-synaptic. As a result of increasing the pulse width during mapping, the patient’s CI outcomes showed significant improvement over 1-year post-CI. Conclusion. A novel FDXR variant associated with mitochondrial dysfunction and post-synaptic ANSD was first identified in a Korean individual. Additionally, 1-year post-CI outcomes were reported for the first time in the literature. Excel- lent audiologic results were obtained, and our results reiterate the correlation between genotype and CI outcomes in ANSD.
참고문헌 (32)
- Meyer E, "Nonsense mutation in TMEM126A causing autosomal recessive optic atrophy and auditory neuropathy", Mol Vis, 16, pp.650~664 (2010)
- Namba K, "Molecular impairment mechanisms of novel OPA1 mutations predicted by molecular modeling in patients with autosomal dominant optic atrophy and auditory neuropathy spectrum disorder", Otol Neurotol, 37(4), pp.394~402 (2016)
- Han KH, "ATP1A3 mutations can cause progressive auditory neuropathy : a new gene of auditory synaptopathy", Sci Rep, 7(1), pp.16504~ (2017)
- Paul A, "FDXR mutations cause sensorial neuropathies and expand the spectrum of mitochondrial Fe-S-synthesis diseases", Am J Hum Genet, 101(4), pp.630~637 (2017)
- Yang C, "Report of a case with ferredoxin reductase(FDXR)gene variants in a Chinese boy exhibiting hearing loss, visual impairment, and motor retardation", Int J Dev Neurosci, 81(4), pp.364~369 (2021)
- Shi Y, "Both human ferredoxins 1 and 2 and ferredoxin reductase are important for iron-sulfur cluster biogenesis", Biochim Biophys Acta, 1823(2), pp.484~492 (2012)
- Nikolopoulos TP, "Auditory dyssynchrony or auditory neuropathy : understanding the pathophysiology and exploring methods of treatment", Int J Pediatr Otorhinolaryngol, 78(2), pp.171~173 (2014)
- Kim BJ, "Mutational and phenotypic spectrum of OTOF-related auditory neuropathy in Koreans : eliciting reciprocal interaction between bench and clinics", J Transl Med, 16(1), pp.330~ (2018)
- Kim Y, "Audiogram configuration, molecular etiology, and outcome of cochlear implantation in postlingual auditory neuropathy spectrum disorder", Otol Neurotol, 44(7), pp.e471~e478 (2023)
- Lee S, "Melatonin inhibits glycolysis in hepatocellular carcinoma cells by downregulating mitochondrial respiration and mTORC1 activity", BMB Rep, 55(9), pp.459~464 (2022)
- Qi J, "AAV-mediated gene therapy restores hearing in patients with DFNB9 deafness", Adv Sci(Weinh), 11(11), pp.e2306788~ (2024)
- Bae SH, "Cochlear implants for patients with common cavity deformities and the impact of electrode positioning", Clin Exp Otorhinolaryngol, 15(1), pp.77~83 (2022)
- Cho SI, "Targeted A-to-G base editing in human mitochondrial DNA with programmable deaminases", Cell, 185(10), pp.1764~1776 (2022)
- Archbold S, "Categories of auditory performance", Ann Otol Rhinol Laryngol Suppl, 166, pp.312~314 (1995)
- Kim BJ, "Long-term audiologic outcomes and potential outcome predictors of cochlear implantation in cochlear aplasia with dilated vestibule : a case series", Clin Otolaryngol, 47(5), pp.599~605 (2022)
- Han KH, "Establishment of a flexible real-time polymerase chain reaction-based platform for detecting prevalent deafness mutations associated with variable degree of sensorineural hearing loss in Koreans", PLoS One, 11(9), pp.e0161756~ (2016)
- Park KS, "Paeoniflorin alleviates skeletal muscle atrophy in ovariectomized mice through the ERα", NRF1 mitochondrial biogenesis pathway, 2022, pp.15(4), 390~
- Umugire A, "Hyaluronan synthase 1 : a novel candidate gene associated with late-onset non-syndromic hereditary hearing loss", Clin Exp Otorhinolaryngol, 15(3), pp.220~229 (2022)
- Chen A, "A novel EYA1 mutation causing alternative RNA splicing in a Chinese family with branchio-oto syndrome : implications for molecular diagnosis and clinical application", Clin Exp Otorhinolaryngol, 16(4), pp.342~358 (2023)
- Kim BJ, "Discovery of CDH23 as a significant contributor to progressive postlingual sensorineural hearing loss in Koreans", PLoS One, 11(10), pp.e0165680~ (2016)
- Kristian T, "Isolation of mitochondria with high respiratory control from primary cultures of neurons and astrocytes using nitrogen cavitation", J Neurosci Methods, 152(1-2), pp.136~143 (2006)
- Richards S, "Standards and guidelines for the interpretation of sequence variants : a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17(5), pp.405~424 (2015)
- Oza AM, "Expert specification of the ACMG", AMP variant interpretation guidelines for genetic hearing loss, 2018, pp.39(11), 1593~1613
- Luo LF, "Nuclear factors : roles related to mitochondrial deafness", Gene, 520(2), pp.79~89 (2013)
- Hutchin TP, "Mitochondrial defects and hearing loss", Cell Mol Life Sci, 57(13-14), pp.1927~1937 (2000)
- Tan WJ, "Role of mitochondrial dysfunction and oxidative stress in sensorineural hearing loss", Hear Res, 434, pp.108783~ (2023)
- Bae JW, "Molecular and clinical characterization of the variable phenotype in Korean families with hearing loss associated with the mitochondrial A1555G mutation", PLoS One, 7(8), pp.e42463~ (2012)
- Chung KW, "Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2(MFN2)mutations", Brain, 129(Pt 8), pp.2103~2118 (2006)
- Shafique S, "Genetic spectrum of autosomal recessive non-syndromic hearing loss in Pakistani families", PLoS One, 9(6), pp.e100146~ (2014)
- Kitani T, "Direct human mitochondrial transfer : a novel concept based on the endosymbiotic theory", Transplant Proc, 46(4), pp.1233~1236 (2014)
- Kesner EE, "Characteristics of mitochondrial transformation into human cells", Sci Rep, 6, pp.26057~ (2016)
- Yi S, "FDXR-associated oculopathy : congenital amaurosis and early-onset severe retinal dystrophy as common presenting features in a Chinese population", Genes(Basel), 14(4), pp.952~ (2023)